The downgrade is a result of several factors, including ProMedica’s high leverage, weaker operating performance and reduced liquidity metrics. S&P favorably viewed ProMedica’s strong market position, solid unrestricted reserves and manageable debt burden.
The outlook is stable, reflecting ProMedica’s strong business position and ongoing strategic investments.
More articles on healthcare finance:
UCLA Health to establish health sciences learning center with $20M gift
7 latest hospital credit downgrades
10 hospitals seeking RCM talent
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
